ON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that its presentation at the UBS Global Life Sciences Conference to be held on September 19-21, 2011 at the Grand Hyatt Hotel in New York has been rescheduled to a different time.
